Atıf Formatları
Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006)
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ö. Atasoy Et Al. , "Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006)," Current Radiopharmaceuticals , vol.18, no.4, pp.318-332, 2025

Atasoy, Ö. Et Al. 2025. Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006). Current Radiopharmaceuticals , vol.18, no.4 , 318-332.

Atasoy, Ö., ANADOL, E., YAR SAĞLAM, A. S., Akdemir, E. Y., Coşkun, Y. Ş., Atak, E., ... Dinçer, Ş.(2025). Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006). Current Radiopharmaceuticals , vol.18, no.4, 318-332.

Atasoy, Özüm Et Al. "Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006)," Current Radiopharmaceuticals , vol.18, no.4, 318-332, 2025

Atasoy, Özüm Et Al. "Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006)." Current Radiopharmaceuticals , vol.18, no.4, pp.318-332, 2025

Atasoy, Ö. Et Al. (2025) . "Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006)." Current Radiopharmaceuticals , vol.18, no.4, pp.318-332.

@article{article, author={Özüm Atasoy Et Al. }, title={Synergistic Potential of GLP-1 Receptor Agonists and Radiotherapy in Breast Cancer Treatment: A New Therapeutic Avenue (TROD-GROG 006)}, journal={Current Radiopharmaceuticals}, year=2025, pages={318-332} }